Published in Breast Cancer Res Treat on December 13, 2009
Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice. J Clin Invest (2011) 1.96
Prolonged complete response after treatment withdrawal in HER2-overexpressed, hormone receptor-negative breast cancer with liver metastases: the prospect of disappearance of an incurable disease. BMC Cancer (2014) 0.96
Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis: A Case-control Study With Comparison to Medically Treated Patients. Ann Surg (2016) 0.96
Surgery of the primary tumor does not improve survival in stage IV breast cancer. Breast Cancer Res Treat (2011) 0.92
Oligometastatic breast cancer: a shift from palliative to potentially curative treatment? Breast Care (Basel) (2014) 0.91
Photoacoustic imaging enhanced by indocyanine green-conjugated single-wall carbon nanotubes. J Biomed Opt (2013) 0.88
SUBMIT: Systemic therapy with or without up front surgery of the primary tumor in breast cancer patients with distant metastases at initial presentation. BMC Surg (2012) 0.86
Primary tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival. Ann Surg Oncol (2013) 0.86
The role of liver-directed surgery in patients with hepatic metastasis from primary breast cancer: a multi-institutional analysis. HPB (Oxford) (2016) 0.84
Prognostic relevance of pretherapeutic gamma-glutamyltransferase in patients with primary metastatic breast cancer. PLoS One (2015) 0.84
Predicting survival of de novo metastatic breast cancer in Asian women: systematic review and validation study. PLoS One (2014) 0.82
Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer? Br J Cancer (2015) 0.80
Resection of the primary tumor in stage IV breast cancer. World J Clin Oncol (2014) 0.78
SEOM clinical guidelines in metastatic breast cancer 2015. Clin Transl Oncol (2015) 0.77
Local Resection of Primary Tumor in Upfront Stage IV Breast Cancer. Breast Care (Basel) (2016) 0.75
Hormone receptor status may impact the survival benefit of surgery in stage iv breast cancer: a population-based study. Oncotarget (2016) 0.75
Survival, healthcare resource use and costs among stage IV ER + breast cancer patients not receiving HER2 targeted therapy: a retrospective analysis of linked SEER-Medicare data. BMC Health Serv Res (2014) 0.75
Surgical treatment of the primary tumour improves the overall survival in patients with metastatic breast cancer: A systematic review and meta-analysis. Mol Clin Oncol (2016) 0.75
Excision of the primary tumour in patients with metastatic breast cancer: a clinical dilemma. Curr Oncol (2012) 0.75
Survival of de novo stage IV breast cancer patients over three decades. J Cancer Res Clin Oncol (2016) 0.75
A step-up approach or open necrosectomy for necrotizing pancreatitis. N Engl J Med (2010) 7.83
Early versus on-demand nasoenteric tube feeding in acute pancreatitis. N Engl J Med (2014) 5.42
Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med (2009) 5.36
Fibrin sealant for prevention of resection surface-related complications after liver resection: a randomized controlled trial. Ann Surg (2012) 3.28
Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer. J Clin Oncol (2006) 2.48
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol (2012) 2.16
Antecolic versus retrocolic route of the gastroenteric anastomosis after pancreatoduodenectomy: a randomized controlled trial. Ann Surg (2014) 2.15
Small gallstones are associated with increased risk of acute pancreatitis: potential benefits of prophylactic cholecystectomy? Am J Gastroenterol (2005) 2.08
A conservative and minimally invasive approach to necrotizing pancreatitis improves outcome. Gastroenterology (2011) 2.04
Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinoma. Cancer (2003) 1.74
Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤ 40 years. Breast Cancer Res Treat (2010) 1.73
Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success. J Pathol (2004) 1.67
Safety of avoiding routine use of axillary dissection in early stage breast cancer: a systematic review. Breast Cancer Res Treat (2010) 1.53
Sentinel node micrometastases in breast cancer do not affect prognosis: a population-based study. Breast Cancer Res Treat (2010) 1.52
Microsurgical techniques for the treatment of breast cancer-related lymphedema: a systematic review. J Reconstr Microsurg (2012) 1.46
Embolization as treatment of choice for bleeding peptic ulcers in high-risk patients. Dig Surg (2009) 1.45
Variation in 'standard care' for breast cancer across Europe: a EUROCARE-3 high resolution study. Eur J Cancer (2010) 1.42
Signalling pathways in vasculogenic mimicry. Biochim Biophys Acta (2010) 1.38
Survivin is an independent prognostic marker for risk stratification of breast cancer patients. Clin Chem (2004) 1.36
P21 Cip1/WAF1 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis. Mod Pathol (2009) 1.29
Cost-effectiveness of adding granulocyte colony-stimulating factor to primary prophylaxis with antibiotics in small-cell lung cancer. J Clin Oncol (2006) 1.24
Breast cancer survival in the US and Europe: a CONCORD high-resolution study. Int J Cancer (2012) 1.23
Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer (2013) 1.22
Breast carcinoma diagnosis, treatment, and prognosis before and after the introduction of mass mammographic screening. Cancer (2004) 1.17
Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study. Breast Cancer Res (2012) 1.16
Clinical management of women with metastatic breast cancer: a descriptive study according to age group. BMC Cancer (2006) 1.14
Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis. Breast Cancer Res Treat (2010) 1.13
The role of surgery in metastatic breast cancer. Eur J Cancer (2011) 1.13
Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancer. Eur J Cancer (2005) 1.10
Early and late morbidity associated with axillary levels I-III dissection in breast cancer. J Surg Oncol (2002) 1.10
Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer. Oncogene (2003) 1.08
Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. J Natl Cancer Inst (2008) 1.07
Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome. Breast Cancer Res Treat (2013) 1.04
Transluminal endoscopic step-up approach versus minimally invasive surgical step-up approach in patients with infected necrotising pancreatitis (TENSION trial): design and rationale of a randomised controlled multicenter trial [ISRCTN09186711]. BMC Gastroenterol (2013) 1.02
Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review. Eur J Cancer (2009) 1.01
Repeat sentinel node biopsy in patients with locally recurrent breast cancer: a systematic review and meta-analysis of the literature. Breast Cancer Res Treat (2013) 0.99
Substantial increase in the use of adjuvant systemic treatment for early stage breast cancer reflects changes in guidelines in the period 1990-2006 in the southeastern Netherlands. Eur J Cancer (2008) 0.99
Trends in the prognosis of patients with primary metastatic breast cancer diagnosed between 1975 and 2002. Breast (2007) 0.99
Laparoscopic fenestration of liver cysts in polycystic liver disease results in a median volume reduction of 12.5%. J Gastrointest Surg (2007) 0.98
Prognostic value of lymph node micrometastases in breast cancer: a multicenter cohort study. Ann Surg Oncol (2010) 0.96
Interobserver variability of laryngeal mucosal premalignant lesions: a histopathological evaluation. Mod Pathol (2011) 0.96
Anxiety after an abnormal screening mammogram is a serious problem. Breast (2011) 0.96
The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute⊕ Study. BMC Surg (2011) 0.96
Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells. Ann Surg (2012) 0.96
COX-2 polymorphisms and the risk for head and neck cancer in white patients. Head Neck (2009) 0.95
ADAMTS8 and ADAMTS15 expression predicts survival in human breast carcinoma. Int J Cancer (2006) 0.95
Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer. Int J Cancer (2002) 0.93
Risk factors for non-sentinel lymph node metastases in patients with breast cancer. The outcome of a multi-institutional study. Ann Surg Oncol (2006) 0.91
Quality of integrated care for patients with nonsmall cell lung cancer: variations and determinants of care. Cancer (2007) 0.91
Modeling the cost effectiveness of secondary febrile neutropenia prophylaxis during standard-dose chemotherapy. J Clin Oncol (2008) 0.90
Re-attendance at biennial screening mammography following a repeated false positive recall. Breast Cancer Res Treat (2014) 0.90
Primary granulocyte colony-stimulating factor prophylaxis during the first two cycles only or throughout all chemotherapy cycles in patients with breast cancer at risk for febrile neutropenia. J Clin Oncol (2013) 0.89
The safety of breast-conserving therapy in patients with breast cancer aged < or = 40 years. Cancer (2007) 0.89
Predictive impact of urokinase-type plasminogen activator: plasminogen activator inhibitor type-1 complex on the efficacy of adjuvant systemic therapy in primary breast cancer. Cancer Res (2004) 0.89
Preoperative biliary drainage for periampullary tumors causing obstructive jaundice; DRainage vs. (direct) OPeration (DROP-trial). BMC Surg (2007) 0.89
Transanal endoscopic microsurgery versus endoscopic mucosal resection for large rectal adenomas (TREND-study). BMC Surg (2009) 0.88
Considering early detection of relapsed ovarian cancer: a review of the literature. Int J Gynecol Cancer (2011) 0.88
False aneurysm of the profunda femoris artery, a rare complication of a proximal femoral fracture. Acta Orthop Belg (2007) 0.88
Delirium after abdominal surgery at a surgical ward with a high standard of delirium care: incidence, risk factors and outcomes. Dig Surg (2009) 0.88
Taxane resistance in breast cancer: a closed HER2 circuit? Biochim Biophys Acta (2012) 0.87
Breast cancers found by screening: earlier detection, lower malignant potential or both? Breast Cancer Res Treat (2002) 0.86
Patient and tumor characteristics of bilateral breast cancer at screening mammography in the Netherlands, a population-based study. Breast Cancer Res Treat (2011) 0.86
Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer? Clin Chem (2006) 0.86
SUBMIT: Systemic therapy with or without up front surgery of the primary tumor in breast cancer patients with distant metastases at initial presentation. BMC Surg (2012) 0.86
The lymph node ratio as a prognostic factor for gastric cancer. Acta Oncol (2013) 0.85
A brachialis muscle rupture diagnosed by ultrasound; case report. Int J Emerg Med (2011) 0.85
Gastric cancer: decreasing incidence but stable survival in the Netherlands. Acta Oncol (2013) 0.84
Bridging trial and decision: a checklist to frame health technology assessments for resource allocation decisions. Value Health (2011) 0.84
Effect of hospital volume on postoperative mortality and survival after oesophageal and gastric cancer surgery in the Netherlands between 1989 and 2009. Eur J Cancer (2012) 0.84
Improving the quality and efficiency of follow-up after curative treatment for breast cancer--rationale and study design of the MaCare trial. BMC Cancer (2007) 0.83
Delirium after emergency/elective open and endovascular aortoiliac surgery at a surgical ward with a high-standard delirium care protocol. Vascular (2010) 0.83
Transferability of model-based economic evaluations: the case of trastuzumab for the adjuvant treatment of HER2-positive early breast cancer in the Netherlands. Value Health (2010) 0.83
High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer. Breast Cancer Res Treat (2006) 0.83
Microsomal epoxide hydrolase genotypes and the risk for head and neck cancer. Head Neck (2008) 0.83
Mammographic changes resulting from benign breast surgery impair breast cancer detection at screening mammography. Eur J Cancer (2012) 0.83
Sentinel Node and Recurrent Breast Cancer (SNARB): results of a nationwide registration study. Ann Surg Oncol (2012) 0.83
Pelvic sepsis after stapled hemorrhoidopexy. World J Gastroenterol (2008) 0.82
Diagnosis, treatment and prognosis of internal mammary lymph node recurrence in breast cancer patients. Breast Cancer Res Treat (2005) 0.82
Major changes in chemotherapy regimens administered to breast cancer patients during 2000-2008 in the Netherlands. Breast J (2013) 0.82
Living with the physical and mental consequences of an ostomy: a study among 1-10-year rectal cancer survivors from the population-based PROFILES registry. Psychooncology (2014) 0.82
Quantitative reverse transcription-PCR assay for detection of mRNA encoding full-length human tissue kallikrein 7: prognostic relevance of KLK7 mRNA expression in breast cancer. Clin Chem (2006) 0.81
Detection of local recurrence following breast-conserving treatment in young women with early breast cancer: optimization of long-term follow-up strategies. Breast (2012) 0.81
Chromosome stability in tonsillar squamous cell carcinoma is associated with HPV16 integration and indicates a favorable prognosis. Int J Cancer (2012) 0.81
Combined anxiety and depressive symptoms before diagnosis of breast cancer. J Affect Disord (2011) 0.81
Pancreatitis, very early compared with normal start of enteral feeding (PYTHON trial): design and rationale of a randomised controlled multicenter trial. Trials (2011) 0.81
Lower sensitivity of screening mammography after previous benign breast surgery. Int J Cancer (2011) 0.81
Up-to-date estimates of breast cancer survival for the years 2000-2004 in 11 European countries: the role of screening and a comparison with data from the United States. Eur J Cancer (2010) 0.81
Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrences. Breast Cancer Res Treat (2012) 0.80
Impact of hospital volume on breast cancer outcome: a population-based study in the Netherlands. Breast Cancer Res Treat (2014) 0.80
The clinical value of lymphatic micrometastases in patients with non-small cell lung cancer. J Thorac Oncol (2010) 0.80
Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients. BMC Cancer (2008) 0.80
Genetic polymorphism in the conjugating enzyme UGT1A1 and the risk of head and neck cancer. Int J Cancer (2010) 0.80
Pancreatitis of biliary origin, optimal timing of cholecystectomy (PONCHO trial): study protocol for a randomized controlled trial. Trials (2012) 0.80